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ABSTRACT 
 
Background: Anti-inflammatory activity of leaves of Bougainvillea spectabilis (family Nyctaginaceae) has already been 
demonstrated in experimental animals. As pain is one of the important components of inflammation, we had set forward a 
study this find out possible analgesic activity of the same in animal models Objective: Evaluation of analgesic effects of, 
Bougainvillea spectabilis in mice models. Methods: 215 gm of fresh dried leaves of Bougainvillea spectabilis (BS) were 
collected from the local area during the flowering season and air dried. Following Methanol extraction, under reduced 
pressure solvent was removed on a rotary evaporator. The lyophilized extract was collected and the yield was 8 gm. That 
was used as an emulsion prepared in propylene glycol and orally administered (20 and 50 mg/kg). Central and peripheral 
analgesic activities of Bougainvillea spectabilis (BS) were evaluated  by tail flick, tail immersion test and writhing test (acetic 
acid induced) respectively. Study Design: This is an experimental study designed on animal models. Results: 
Bougainvillea spectabilis (BS) had shown no analgesic action in central analgesic model at different hours as the reaction 
time was less than 10 seconds at all time interval. With regard to peripheral analgesic activity, maximal activity was 
observed at 50 mg/kg b.w. The mean writhes ± standard deviation were 42.7±0.9 and 40±0.5 respectively in BS (20 mg/kg) 
and BS (50 mg/kg) in comparison to standard drug aspirin (33.3±0.4), control mice being 55.3±0.4. Conclusion: Our data 
indicates that Bougainvillea spectabilis (50 mg/kg) has a significant peripheral analgesic activity. Without isolating the active 
principles it’s extremely difficult to pinpoint the mechanisms contributing to the observed analgesic activities of 
Bougainvillea spectabilis and extrapolate that in clinical practice. 
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INTRODUCTION 
 
Bougainvillea spectabillis (BS) is popular as an 
ornamental plant In India and other tropical 
countries though it has a long tradition of medicinal 
use. Scientists are not fully aware of the fact that all 
parts of plants including roots are used in forms of 
infusions (mostly flowers). Sometimes decoctions 
(stems, leaves, roots) and tinctures of the same 
preparation is preferred. 
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Medical practitioners of Tamilnadu has been using 
this plant product to treat inflammation.[1] It also 
showed some effect in sore throat, flu, fever, 
diarrhea, and diabetes (it contain insulin like 
chemical pinitol).[2,3] It protects liver probably due to 
esculetin content, used in asthma and bronchitis, to 
regulate menstruation and stop leucorrhea and 
treatment of gastrointestinal bleeding and epigastric 
pain.  
It is obvious that like every herb, Bougainvillea 
spectabillis has many chemotypes. It contains 
anthraquinones, tannins, pinitol, esculetin, 
glycosides, alkaloids, quercetin, and many other 
components responsible for variable therapeutic 
effects. In animal experimental models, water 
extracts of BS had shown significant lowering of 
estrogen in female and testosterone level in male 
mice. Alcohol extract of BS reduces bad cholesterol 
level and hence the risk of cardiovascular diseases. 
Bougenvillea leaves. (ethanolic extract) showed 
significant reduction of serum calcium and 
potassium and increase in phosphate, serum urea and 
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creatinine concentration. Therefore, continuous 
usage of ethanolic extract of BS might adversely 
affect normal functions of kidney and liver. 
Mandal et al and Joshi et al observed anti-
inflammatory activities of BS (methanolic extract of 
leaves) in experimental models.[4,5] Though limited 
information is available regarding its 
phytochemistry, pharmacological and toxicological 
activities of BS are available in plant research. As 
part of a continuing search for plant derived 
analgesic agents, this study was undertaken to 
explore the potential application of methanolic 
extract of Bougainvillea spectabilis (BS) leaves as 
an analgesic agent in different animal models. 
 
Objectives 
Evaluation of analgesic effects of Bougainvillea 
spectabilis (BS) in mice. 
 
MATERIALS AND METHODS 
 
Animals 
Swiss albino mice of average weight 15-25 g. of 
either sex were acclimatized for one week before 
starting the experiments. Standard laboratory 
conditions and temperature (24±50C) were given to 
all animals. Animals were provided with free access 
to water ad libitum and commercial pellet feed. 12 hr 
light/dark cycle was maintained. The study was 
approved by the Institutional Animal Ethics 
Committee and followed OECD guidelines. 
CPCSEA/544 is the registration no of Institutional 
Animal Ethics Committee of IPGME&R, Kolkata. 
 
Preparation of Plant Product 
The identity of the plant was authenticated by the 
Botanical Survey of India. Fresh leaves from the 
flowering plant Bougainvillea spectabilis (BS) were 
collected from the local area and air-dried (215.00g). 
Following methanol extraction solvent was removed 
on a rotary evaporator under reduced pressure. The 
yield was 8 gm after the extract was freeze-dried 
(lyophilized). Propylene glycol was used to prepare 
an emulsion. Bougainvillea spectabilis (BS) in an 
initial pilot study was administered up to a 
maximum of 200 mg/kg of b.w. 50kg/kg. of BS 
leaves had shown maximum analgesic effect. 
 
a) Method for evaluation of central analgesic activity. 
b) D’ Armour et al., (1941) invented this method for 
evaluation of central analgesic activity later modified 
by Ther et al. (1963).[6,7] Forty eight rats were taken 
and divided into four groups of twelve mice each. 
The groups were treated as follows: 
 
Group (n=12) Treatment 
Group I Control 
Group II Standard drug, Pethidine (12 mg/kg) 
Group III Bougainvillea spectabilis(BS) (20mg/kg) 
Group IV Bougainvillea spectabilis(BS) ,(50mg/kg) 
Tail Flick Test  
An analgesiometer was provided by Model Mark I 
Techno Electronic, Lucknow. The tail of each mouse 
was placed 2 mm above the nichrome wire of the 
instrument. 5-amp current was passed and the 
radiant heat was generated. It was directed to the 
proximal third of the tail. The reaction time was 
recorded as the time taken by each animal to 
withdraw (flick) the tail away from the hot wire. 
Mice that failed to withdraw its tail within 15 
seconds was excluded from the experiment. The 
normal reaction time was recorded before 
administration of the test compound or the standard 
drug. The reaction time was measured at 30, 60, 90, 
120 and 150 min after administration of test and 
standard drugs. The analgesic activity was classified 
as positive if the mouse failed to withdraw its tail 
within 15 sec of exposure.  
 
c) Tail immersion method:  
This method of the test was adopted by Ramabadran 
et al. (1989).[8] Mice were divided into four groups. 
Each group contains 12 animals. Tail (lower 5.0 cm) 
of the mice was then dipped in a beaker of water (55 
± 0.5ºC). The reaction time is the time required to 
withdraw the tail out of water. The animals 
discarded were those who could not lift its tail out of 
the water within 10 seconds. The basal reaction time 
for all the animals was recorded as the 0-minute 
observation. The reaction time was measured at 
different (30, 60, 90,120 and 150) min after 
administration of test and standard drugs. A normal 
control, without any treatment was also maintained. 
The reaction time was noted 30, 60, 90, 120 and 150 
min after drug administration. 
 
d) Model for evaluation of Peripheral analgesic 
activity 
Acetic acid induced writhing test 
This was based on the method described by Koster et 
al. (1959).[9] Albino mice of either sex were divided 
into four groups of twelve animals each. 
Bougainvillea spectabilis (20 and 50 mg/kg of b.w) 
at doses of 0.1 ml/10 gm, aspirin (30 mg/kg; 
standard) were orally administered respectively to 
the three groups. Intraperitoneal injection of 0.6 % 
v/v acetic acid solution in water at a dose of 10 
ml/kg. A control group without any drug treatment 
was also treated with acetic acid. Immediately after 
administration of acetic acid, the number of stretches 
(a syndrome, characterized by a wave of contraction 
of the abdominal musculature followed by extension 
of hind limbs) was counted for 15 min. Evidence for 
the presence of analgesia was measured by reduction 
in the number of writhes as compared to the control 
group. This is expressed as percent inhibition of 
writhing, which is calculated according to the 
following formula: 
 
               Mean number of writhes   – Mean number of writhes 
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                       in control group          in test group 
% Inhibition =          
           Mean number of writhes in control group 
 
Statistical Analysis: SPSS-20 was used as software 
to measure test of significance (evaluated by 
ANOVA), with P< 0.05 implying significance. The 
results were expressed as mean ± standard deviation 
and in terms of percentages. 
 
Toxicity studies: 
The potential toxicity of BS was measured in a 
subacute toxicity model in Swiss albino mice by 
Ghosh in 1984[10].BS was given orally to mice in a 
stepwise fashion. Minimum dose of 100 mg/Kg to a 
maximum of 1.5 g/kg b.w. Highest dose was given 
for an additional two weeks. Renal function tests 
(urea and Creatinine) and Liver function tests (serum 
glutamate oxaloacetate transaminase (SGOT), 
Serum glutamate pyruvate transaminase (SGPT), 
alkaline phosphatase were carried out using 
appropriate kits.  
 
RESULTS 
 
Bougainvillea spectabilis (BS) had shown no 
analgesic action in central analgesic model at 
different hours. Reaction time was less than 10 
seconds at all time interval. [Figure 2], [Figure 3] 
With regard to peripheral analgesic activity, 
maximal activity was observed at 50 mg/kg b.w,that 
remained little bit lesser at 20 mg/kg. The mean 
writhes ± standard deviation were 42.7±0.9 and 
40±0.5 respectively, control mice being 
55.3±0.4.[Figure 1] The degree of inhibition at these 
doses were 27.6% and 22.6% respectively and 
statistically significant as compared to controls 
(P<0.001). However this analgesic activity was 
lower than that obtained with aspirin where the mean 
writhes ± SD was 33.3±0.4 causing 39.8% 
inhibition. Algesia is caused acetic acid, which 
liberates endogenous substances including serotonin, 
histamine, prostaglandins, bradykinine and 
substance P.  
 
 
Figure 1: Effects of methanolic extract of Bougainvillea 
spectabilis by acetic acid induced writhing test. 
 
Figure 2: Effects of methanolic extract of Bougainvillea 
spectabilis by tail flick method. 
 
 
Figure 3: Effects of methanolic extract of Bougainvillea 
spectabilis by tail immersion method. 
 
DISCUSSION 
 
Peripheral nociceptors are responsible for causing 
sensitization, which may lead to hyperalgesia.  It 
occurs when different chemical products, such as 
bradykinin, 5-HT, histamine are released near 
nociceptor terminals after or during tissue 
inflammation. Algesia is caused by endogenous 
substances including serotonin, histamine, 
prostaglandins, bradykinine and substance P 
liberated by acetic acid. Inflammation may destroy 
cells near nociceptor when exposed to a noxious 
stimulus. Proteolytic enzymes are released by dying 
cells that react with circulating globulins to from 
bradykinin. Activation of a second messenger 
system and sensitizing of the nerve ending happened 
after binding of bradykinin to a receptor on the 
membrane of the nociceptor (William, 1998b).[11,12] 
It also provoked the release of neuropeptides such as 
substance P, neurokinin A, and CGRP as described 
by Geppetti, in 1993.[13]. 
Data in the experiments shown by Mandal et al 
indicated that BS (50 mg/Kg of body weight) had a 
certain degree of both anti-inflammatory (acute and 
chronic) activity, as it was capable of decreasing 
edema formation in all kinds of anti-inflammatory 
models. Garcia, in 1978 had shown that bradykinin 
was more potent than histamine and serotonin as 
mediator of pain, which was also established by 
Moncada et al., in 1978. He emphasized the role of 
prostaglandins in sensitizing the nerve endings to the 
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effects of bradykinin and other algogens.[14] 
Underlying mechanism of nerve ending sensitization 
is either opening up of the ion channels or by 
activation of second messenger. Therefore, it is 
possible that the peripheral analgesic activity of 
Bougainvillea spectabilis leaves (methanolic extract) 
observed was due to its concomitant anti-
inflammatory activity already established by Mandal 
et al in 2015. 
 
Absence of toxicity of BS in a subacute toxicity 
model: 
Sub-acute toxicity studies using the methanolic 
extract of BS leaves showed no major toxicity as 
evidenced by the absence of any hepatic or renal 
damage; the levels of SGOT, SGPT, Alkaline 
phosphatase, urea and creatinine of control and 
treated groups were not significantly different when 
tested statistically. 
 
CONCLUSION 
 
The results of the present study revealed only 
peripheral analgesic activity. Without isolating the 
active principles, it’s extremely difficult to pinpoint 
the mechanisms contributing to the observed 
analgesic activity of Bougainvillea spectabilis and 
extrapolate that in clinical practice. 
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